Status:
COMPLETED
Therapeutic Potential of Kappa-Opioids Against Cocaine - 1
Lead Sponsor:
National Institute on Drug Abuse (NIDA)
Conditions:
Cocaine-Related Disorders
Eligibility:
All Genders
21-50 years
Brief Summary
The purpose of this study is to characterize the effects of enadoline compared to hydromorphone and butorphanol.
Eligibility Criteria
Inclusion Criteria:
opiate experienced, healthy
Exclusion Criteria:
physical dependence on opioids, barbiturates or alcohol
Key Trial Info
Start Date :
July 1 1996
Trial Type :
OBSERVATIONAL
End Date :
December 1 1998
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT00000323
Start Date
July 1 1996
End Date
December 1 1998
Last Update
January 12 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Johns Hopkins University (BPRU) Bayview Campus
Baltimore, Maryland, United States, 21224 6823